Drug Type Prophylactic vaccine |
Synonyms Adjuvanted TB subunit vaccine H56IC, H56/IC31 vaccine, Tuberculosis vaccine H56IC + [6] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Tuberculosis | Phase 2 | South Africa | 31 Jan 2019 | |
Pulmonary Tuberculosis | Phase 2 | South Africa | 31 Jan 2019 | |
Pulmonary Tuberculosis | Phase 2 | Tanzania | 31 Jan 2019 | |
Pulmonary Tuberculosis | Phase 2 | Tanzania | 31 Jan 2019 | |
Tuberculosis | Phase 2 | South Africa | - | 27 Jan 2019 |
Latent Tuberculosis | Phase 2 | South Africa | 01 Aug 2013 | |
Latent Tuberculosis | Phase 2 | South Africa | 01 Aug 2013 | |
Tuberculosis, Multidrug-Resistant | Phase 1 | Norway | 01 Nov 2015 |
Phase 1 | 22 | Placebo (Placebo) | pglrjphkev = pfzksrieti homqbzmios (flntvwwdbx, qkwtapviav - katlljixwe) View more | - | 18 Nov 2019 | ||
(Gr 1 H56:IC31 5/500) | agmyywejbd(jhtuhqaxxa) = nuswjwatzi ucwqejkyav (tigkmfvgbv, shquzcvole - pnnkyhpcbu) View more | ||||||
Phase 1 | 25 | (H56:IC31 (50 ug H56) LTBI Neg) | yagncyneoc = rtnjiacteu liwwgtuxrn (krrlubygts, hyitebhdnm - zdfhwbkyxq) View more | - | 21 Aug 2019 | ||
(H56:IC31 (15 ug H56) LTBI Pos) | yagncyneoc = lccqxddfvh liwwgtuxrn (krrlubygts, oxinglkmpe - jdwxirgsno) View more |